Improving the outcome of adoptive cell transfer by targeting tumor escape

Karen M. Kaluza, Richard Vile

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Adoptive T-cell transfer is among the most promising immunotherapies against cancer. To continue increasing the potential of this therapy, our studies focus on the inhibition of tumor recurrence. Recently, we have demonstrated several ways in which combination therapies involving multiple T-cell populations and immunostimulatory chemotherapy can enhance long-term survival.

Original languageEnglish (US)
Article numbere22059
Issue number1
StatePublished - Jan 2013


  • Adoptive T cell therapy
  • Cyclophosphamide
  • Immunostimulatory chemotherapy
  • Melanoma
  • Tumor escape

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology


Dive into the research topics of 'Improving the outcome of adoptive cell transfer by targeting tumor escape'. Together they form a unique fingerprint.

Cite this